TechValidate Research on TriSalus™ Life Sciences

These pages present data that TechValidate has sourced via direct research with verified customers and users of TriSalus™ Life Sciences. TechValidate stands behind the authenticity of all published data. Learn more »



11 Published TechFacts

1 Published Chart



Selected Research Highlights


TriSalus™ Life Sciences Customer Research

What is the primary clinical benefit of SIS?

What is the primary clinical benefit of SIS?

Improved Tumor Response
45%
Improved Therapy Uptake
36%
Improved Patient Outcomes
18%

TriSalus™ Life Sciences Customer Satisfaction Rating

A Director of Interventional Radiology at a small hospital system would be very likely to recommend TriSalus™ Life Sciences for this reason:

Very dependable catheter. Pressured enable delivery and reflux protection have become invaluable in my practice.

TriSalus™ Life Sciences Customer Testimonial

What is the primary reason you use SIS in these procedures?

Controlled delivery, precise catheter placement (no motion during respiration), SIRT—deliver entire intended dose to target area, improved tumor necrosis with PEDD.

Jason Iannuccilli, Director of Interventional Oncology, Lifespan Corporation



More to Explore



About TriSalus™ Life Sciences

Our commitment to improving outcomes in cancer care is renewed as TriSalus Life Sciences. TriSalus develops infusion technology that helps physicians deliver therapy deeper into solid tumors while protecting healthy tissues, giving patients greater confidence in their cancer care.

TriSalus™ Life Sciences Website   TriSalus™ Life Sciences Website